Prosight Management as of March 31, 2023
Portfolio Holdings for Prosight Management
Prosight Management holds 41 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 10.3 | $22M | 447k | 48.47 | |
| Galapagos Nv Spon Adr (GLPG) | 6.9 | $15M | 376k | 38.64 | |
| Mirum Pharmaceuticals (MIRM) | 6.5 | $14M | 568k | 24.02 | |
| Humana (HUM) | 5.5 | $12M | 24k | 485.46 | |
| Centene Corporation (CNC) | 4.8 | $10M | 161k | 63.21 | |
| Kezar Life Sciences | 4.7 | $10M | 3.2M | 3.13 | |
| BioCryst Pharmaceuticals (BCRX) | 4.2 | $9.0M | 1.1M | 8.34 | |
| Alkermes SHS (ALKS) | 4.2 | $8.9M | 316k | 28.19 | |
| Horizon Therapeutics Pub L SHS | 4.2 | $8.8M | 81k | 109.14 | |
| Oric Pharmaceuticals (ORIC) | 4.2 | $8.8M | 1.5M | 5.70 | |
| Neurocrine Biosciences (NBIX) | 3.8 | $8.1M | 80k | 101.22 | |
| Meiragtx Holdings (MGTX) | 3.6 | $7.7M | 1.5M | 5.17 | |
| Adc Therapeutics Sa SHS (ADCT) | 3.0 | $6.4M | 3.3M | 1.95 | |
| Arcturus Therapeutics Hldg I (ARCT) | 2.9 | $6.1M | 255k | 23.97 | |
| Shattuck Labs (STTK) | 2.8 | $5.9M | 2.0M | 2.94 | |
| Abcellera Biologics (ABCL) | 2.7 | $5.7M | 754k | 7.54 | |
| UnitedHealth (UNH) | 2.4 | $5.2M | 11k | 472.59 | |
| Option Care Health Com New (OPCH) | 2.3 | $4.9M | 155k | 31.77 | |
| Quidel Corp (QDEL) | 2.0 | $4.3M | 48k | 89.09 | |
| Cue Biopharma (CUE) | 1.9 | $4.1M | 1.2M | 3.57 | |
| Johnson & Johnson (JNJ) | 1.9 | $3.9M | 25k | 155.00 | |
| Inari Medical Ord | 1.8 | $3.8M | 62k | 61.74 | |
| Aldeyra Therapeutics (ALDX) | 1.8 | $3.8M | 383k | 9.93 | |
| Pacira Pharmaceuticals (PCRX) | 1.8 | $3.7M | 91k | 40.81 | |
| Longboard Pharmaceuticals In | 1.7 | $3.6M | 901k | 4.01 | |
| Erasca (ERAS) | 1.7 | $3.5M | 1.2M | 3.01 | |
| Compass Therapeutics (CMPX) | 1.1 | $2.2M | 678k | 3.27 | |
| Graphite Bio | 1.0 | $2.1M | 877k | 2.45 | |
| Kalvista Pharmaceuticals (KALV) | 0.9 | $1.9M | 240k | 7.86 | |
| Galapagos Nv Call Call Option | 0.7 | $1.5M | 40k | 38.64 | |
| Modivcare | 0.6 | $1.3M | 16k | 84.08 | |
| Teladoc (TDOC) | 0.6 | $1.2M | 46k | 25.90 | |
| Kezar Life Sciences Call Call Option | 0.3 | $626k | 200k | 3.13 | |
| Insmed Com Par $.01 (INSM) | 0.2 | $449k | 26k | 17.05 | |
| 2seventy Bio Common Stock | 0.2 | $434k | 43k | 10.20 | |
| Morphic Hldg (MORF) | 0.2 | $319k | 8.5k | 37.64 | |
| Aziyo Biologics Cl A Com (ELUT) | 0.1 | $297k | 196k | 1.51 | |
| Bridgebio Pharma (BBIO) | 0.1 | $216k | 13k | 16.58 | |
| Oncology Institu (TOI) | 0.1 | $191k | 282k | 0.68 | |
| Lifestance Health Group (LFST) | 0.0 | $67k | 9.0k | 7.43 | |
| Spdr Ser Tr S&p Biotech (XBI) | 0.0 | $21k | 273.00 | 76.21 |
